Document is current
Any future updates will be listed below
-
Authors
Kerpel-Fronius, Anna
Monostori, Zsuzsanna
Kovacs, Gabor
Ostoros, Gyula
Horvath, Istvan
Solymosi, Diana
Pipek, Orsolya
Szatmari, Ferenc
Kovacs, Anita
Markoczy, Zsolt
Rojko, Livia
Renyi-Vamos, Ferenc
Hoetzenecker, Konrad
Bogos, Krisztina
Megyesfalvi, Zsolt
Dome, Balazs
-
Funding
Funding for this research was provided by:
Hungarian Scientific Research Fund (KH130356, KKP126790 and 2020-1.1.6-JÖVŐ)
Austrian Science Fund (FWF I3522, FWF I3977 and I4677)
Hungarian Ministry for Innovation and Technology (UNKP-20-3 and UNKP-21-3)
- License Information
-
More Information
Article History
Received: 8 November 2021
Revised: 20 December 2021
Accepted: 13 January 2022
First Online: 5 March 2022
Declarations
:
: The scientific guarantor of this publication is Anna Kerpel-Fronius.
: The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
: No complex statistical methods were necessary for this paper.
: Written informed consent was obtained from all subjects (patients) in this study.
: The HUNCHEST pilot project is a prospective, multicenter, nationwide lung cancer screening trial conducted in accordance with the guidelines of the Helsinki Declaration (as revised in 2013) of the World Medical Association. The study was approved by the national level ethics committee (Hungarian Scientific and Research Ethics Committee of the Medical Research Council, ETT-TUKEB, 002524–005/2014/OTIG) and the institutional review boards of all participating institutions. All study participants provided written informed consent.
: • prospective• diagnostic or prognostic study• multicenter study
